Diabetes drug shows promise against multiple sclerosis (w/Podcast)

A drug currently FDA-approved for use in diabetes shows some protective effects in the brains of patients with relapsing remitting multiple sclerosis, researchers at the University of Illinois at Chicago College of Medicine report in a study currently available online in the Journal of Neuroimmunology.

Read the whole article on Physorg

More from Physorg